nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—breast cancer	0.441	1	CbGaD
Risedronate—FDPS—nipple—breast cancer	0.00465	0.109	CbGeAlD
Risedronate—FDPS—skin of body—breast cancer	0.00298	0.0695	CbGeAlD
Risedronate—FDPS—endometrium—breast cancer	0.00281	0.0655	CbGeAlD
Risedronate—FDPS—uterus—breast cancer	0.00259	0.0604	CbGeAlD
Risedronate—FDPS—pituitary gland—breast cancer	0.00254	0.0593	CbGeAlD
Risedronate—FDPS—adipose tissue—breast cancer	0.00253	0.0591	CbGeAlD
Risedronate—FDPS—female reproductive system—breast cancer	0.00232	0.0543	CbGeAlD
Risedronate—FDPS—adrenal gland—breast cancer	0.00227	0.053	CbGeAlD
Risedronate—FDPS—bone marrow—breast cancer	0.00219	0.0513	CbGeAlD
Risedronate—FDPS—female gonad—breast cancer	0.00212	0.0494	CbGeAlD
Risedronate—FDPS—endocrine gland—breast cancer	0.00197	0.0459	CbGeAlD
Risedronate—Zoledronate—ABCC1—breast cancer	0.00195	0.644	CrCbGaD
Risedronate—PTGS2—embryo—breast cancer	0.00147	0.0343	CbGeAlD
Risedronate—FDPS—lymph node—breast cancer	0.00136	0.0318	CbGeAlD
Risedronate—PTGS2—epithelium—breast cancer	0.0012	0.028	CbGeAlD
Risedronate—PTGS2—skin of body—breast cancer	0.00114	0.0266	CbGeAlD
Risedronate—PTGS2—endometrium—breast cancer	0.00108	0.0251	CbGeAlD
Risedronate—PTGS2—uterus—breast cancer	0.000991	0.0231	CbGeAlD
Risedronate—PTGS2—pituitary gland—breast cancer	0.000973	0.0227	CbGeAlD
Risedronate—PTGS2—adipose tissue—breast cancer	0.00097	0.0226	CbGeAlD
Risedronate—PTGS2—female reproductive system—breast cancer	0.000891	0.0208	CbGeAlD
Risedronate—PTGS2—adrenal gland—breast cancer	0.00087	0.0203	CbGeAlD
Risedronate—PTGS2—bone marrow—breast cancer	0.000841	0.0196	CbGeAlD
Risedronate—PTGS2—female gonad—breast cancer	0.000811	0.0189	CbGeAlD
Risedronate—PTGS2—endocrine gland—breast cancer	0.000754	0.0176	CbGeAlD
Risedronate—Histamine Phosphate—CYP2D6—breast cancer	0.000582	0.192	CrCbGaD
Risedronate—PTGS2—lymph node—breast cancer	0.000521	0.0122	CbGeAlD
Risedronate—Histamine Phosphate—CYP3A4—breast cancer	0.000499	0.164	CrCbGaD
Risedronate—Gastrointestinal pain—Paclitaxel—breast cancer	8.24e-05	0.000203	CcSEcCtD
Risedronate—Diarrhoea—Gemcitabine—breast cancer	8.23e-05	0.000203	CcSEcCtD
Risedronate—Infection—Capecitabine—breast cancer	8.21e-05	0.000203	CcSEcCtD
Risedronate—Dizziness—Irinotecan—breast cancer	8.17e-05	0.000202	CcSEcCtD
Risedronate—Haemoglobin—Epirubicin—breast cancer	8.15e-05	0.000201	CcSEcCtD
Risedronate—Shock—Capecitabine—breast cancer	8.13e-05	0.000201	CcSEcCtD
Risedronate—Rhinitis—Epirubicin—breast cancer	8.13e-05	0.000201	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—breast cancer	8.12e-05	0.0002	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—breast cancer	8.12e-05	0.0002	CcSEcCtD
Risedronate—Nervous system disorder—Capecitabine—breast cancer	8.11e-05	0.0002	CcSEcCtD
Risedronate—Haemorrhage—Epirubicin—breast cancer	8.11e-05	0.0002	CcSEcCtD
Risedronate—Eye disorder—Methotrexate—breast cancer	8.1e-05	0.0002	CcSEcCtD
Risedronate—Diarrhoea—Fluorouracil—breast cancer	8.1e-05	0.0002	CcSEcCtD
Risedronate—Tinnitus—Methotrexate—breast cancer	8.08e-05	0.000199	CcSEcCtD
Risedronate—Pharyngitis—Epirubicin—breast cancer	8.05e-05	0.000199	CcSEcCtD
Risedronate—Cardiac disorder—Methotrexate—breast cancer	8.04e-05	0.000198	CcSEcCtD
Risedronate—Skin disorder—Capecitabine—breast cancer	8.03e-05	0.000198	CcSEcCtD
Risedronate—Urinary tract disorder—Epirubicin—breast cancer	8.01e-05	0.000198	CcSEcCtD
Risedronate—Urticaria—Paclitaxel—breast cancer	8e-05	0.000197	CcSEcCtD
Risedronate—Oedema peripheral—Epirubicin—breast cancer	7.99e-05	0.000197	CcSEcCtD
Risedronate—Connective tissue disorder—Epirubicin—breast cancer	7.97e-05	0.000197	CcSEcCtD
Risedronate—Abdominal pain—Paclitaxel—breast cancer	7.97e-05	0.000196	CcSEcCtD
Risedronate—Body temperature increased—Paclitaxel—breast cancer	7.97e-05	0.000196	CcSEcCtD
Risedronate—Urethral disorder—Epirubicin—breast cancer	7.95e-05	0.000196	CcSEcCtD
Risedronate—Hepatobiliary disease—Doxorubicin—breast cancer	7.9e-05	0.000195	CcSEcCtD
Risedronate—Angiopathy—Methotrexate—breast cancer	7.86e-05	0.000194	CcSEcCtD
Risedronate—Vomiting—Irinotecan—breast cancer	7.86e-05	0.000194	CcSEcCtD
Risedronate—Vomiting—Mitoxantrone—breast cancer	7.86e-05	0.000194	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—breast cancer	7.84e-05	0.000193	CcSEcCtD
Risedronate—Immune system disorder—Methotrexate—breast cancer	7.83e-05	0.000193	CcSEcCtD
Risedronate—Dizziness—Fluorouracil—breast cancer	7.82e-05	0.000193	CcSEcCtD
Risedronate—Mediastinal disorder—Methotrexate—breast cancer	7.81e-05	0.000193	CcSEcCtD
Risedronate—Rash—Mitoxantrone—breast cancer	7.79e-05	0.000192	CcSEcCtD
Risedronate—Rash—Irinotecan—breast cancer	7.79e-05	0.000192	CcSEcCtD
Risedronate—Dermatitis—Mitoxantrone—breast cancer	7.78e-05	0.000192	CcSEcCtD
Risedronate—Dermatitis—Irinotecan—breast cancer	7.78e-05	0.000192	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Docetaxel—breast cancer	7.78e-05	0.000192	CcSEcCtD
Risedronate—Headache—Irinotecan—breast cancer	7.74e-05	0.000191	CcSEcCtD
Risedronate—Headache—Mitoxantrone—breast cancer	7.74e-05	0.000191	CcSEcCtD
Risedronate—Insomnia—Docetaxel—breast cancer	7.72e-05	0.000191	CcSEcCtD
Risedronate—Paraesthesia—Docetaxel—breast cancer	7.67e-05	0.000189	CcSEcCtD
Risedronate—Vomiting—Gemcitabine—breast cancer	7.65e-05	0.000189	CcSEcCtD
Risedronate—Dyspnoea—Docetaxel—breast cancer	7.61e-05	0.000188	CcSEcCtD
Risedronate—Mental disorder—Methotrexate—breast cancer	7.59e-05	0.000187	CcSEcCtD
Risedronate—Rash—Gemcitabine—breast cancer	7.59e-05	0.000187	CcSEcCtD
Risedronate—Dermatitis—Gemcitabine—breast cancer	7.58e-05	0.000187	CcSEcCtD
Risedronate—Eye disorder—Epirubicin—breast cancer	7.58e-05	0.000187	CcSEcCtD
Risedronate—Tinnitus—Epirubicin—breast cancer	7.56e-05	0.000186	CcSEcCtD
Risedronate—Malnutrition—Methotrexate—breast cancer	7.54e-05	0.000186	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—breast cancer	7.54e-05	0.000186	CcSEcCtD
Risedronate—Headache—Gemcitabine—breast cancer	7.54e-05	0.000186	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Capecitabine—breast cancer	7.53e-05	0.000186	CcSEcCtD
Risedronate—Cardiac disorder—Epirubicin—breast cancer	7.52e-05	0.000186	CcSEcCtD
Risedronate—Vomiting—Fluorouracil—breast cancer	7.52e-05	0.000186	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—breast cancer	7.52e-05	0.000186	CcSEcCtD
Risedronate—Dyspepsia—Docetaxel—breast cancer	7.52e-05	0.000185	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—breast cancer	7.5e-05	0.000185	CcSEcCtD
Risedronate—Insomnia—Capecitabine—breast cancer	7.48e-05	0.000184	CcSEcCtD
Risedronate—Rash—Fluorouracil—breast cancer	7.46e-05	0.000184	CcSEcCtD
Risedronate—Dermatitis—Fluorouracil—breast cancer	7.45e-05	0.000184	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—breast cancer	7.45e-05	0.000184	CcSEcCtD
Risedronate—Paraesthesia—Capecitabine—breast cancer	7.42e-05	0.000183	CcSEcCtD
Risedronate—Hypersensitivity—Paclitaxel—breast cancer	7.42e-05	0.000183	CcSEcCtD
Risedronate—Headache—Fluorouracil—breast cancer	7.41e-05	0.000183	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—breast cancer	7.41e-05	0.000183	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—breast cancer	7.39e-05	0.000182	CcSEcCtD
Risedronate—Gastrointestinal disorder—Docetaxel—breast cancer	7.37e-05	0.000182	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—breast cancer	7.37e-05	0.000182	CcSEcCtD
Risedronate—Dyspnoea—Capecitabine—breast cancer	7.37e-05	0.000182	CcSEcCtD
Risedronate—Fatigue—Docetaxel—breast cancer	7.36e-05	0.000182	CcSEcCtD
Risedronate—Angiopathy—Epirubicin—breast cancer	7.36e-05	0.000181	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—breast cancer	7.35e-05	0.000181	CcSEcCtD
Risedronate—Nausea—Mitoxantrone—breast cancer	7.34e-05	0.000181	CcSEcCtD
Risedronate—Nausea—Irinotecan—breast cancer	7.34e-05	0.000181	CcSEcCtD
Risedronate—Immune system disorder—Epirubicin—breast cancer	7.32e-05	0.000181	CcSEcCtD
Risedronate—Mediastinal disorder—Epirubicin—breast cancer	7.31e-05	0.00018	CcSEcCtD
Risedronate—Pain—Docetaxel—breast cancer	7.3e-05	0.00018	CcSEcCtD
Risedronate—Constipation—Docetaxel—breast cancer	7.3e-05	0.00018	CcSEcCtD
Risedronate—Back pain—Methotrexate—breast cancer	7.3e-05	0.00018	CcSEcCtD
Risedronate—Dyspepsia—Capecitabine—breast cancer	7.28e-05	0.00018	CcSEcCtD
Risedronate—Arrhythmia—Epirubicin—breast cancer	7.24e-05	0.000179	CcSEcCtD
Risedronate—Asthenia—Paclitaxel—breast cancer	7.23e-05	0.000178	CcSEcCtD
Risedronate—Nausea—Gemcitabine—breast cancer	7.15e-05	0.000176	CcSEcCtD
Risedronate—Gastrointestinal disorder—Capecitabine—breast cancer	7.14e-05	0.000176	CcSEcCtD
Risedronate—Fatigue—Capecitabine—breast cancer	7.13e-05	0.000176	CcSEcCtD
Risedronate—Pruritus—Paclitaxel—breast cancer	7.13e-05	0.000176	CcSEcCtD
Risedronate—Mental disorder—Epirubicin—breast cancer	7.1e-05	0.000175	CcSEcCtD
Risedronate—Pain—Capecitabine—breast cancer	7.07e-05	0.000174	CcSEcCtD
Risedronate—Constipation—Capecitabine—breast cancer	7.07e-05	0.000174	CcSEcCtD
Risedronate—Malnutrition—Epirubicin—breast cancer	7.06e-05	0.000174	CcSEcCtD
Risedronate—Nausea—Fluorouracil—breast cancer	7.03e-05	0.000173	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—breast cancer	7.01e-05	0.000173	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—breast cancer	6.99e-05	0.000173	CcSEcCtD
Risedronate—Gastrointestinal pain—Docetaxel—breast cancer	6.98e-05	0.000172	CcSEcCtD
Risedronate—Anaemia—Methotrexate—breast cancer	6.97e-05	0.000172	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—breast cancer	6.96e-05	0.000172	CcSEcCtD
Risedronate—Flatulence—Epirubicin—breast cancer	6.95e-05	0.000172	CcSEcCtD
Risedronate—Diarrhoea—Paclitaxel—breast cancer	6.89e-05	0.00017	CcSEcCtD
Risedronate—Back pain—Epirubicin—breast cancer	6.83e-05	0.000168	CcSEcCtD
Risedronate—Angiopathy—Doxorubicin—breast cancer	6.81e-05	0.000168	CcSEcCtD
Risedronate—Muscle spasms—Epirubicin—breast cancer	6.79e-05	0.000167	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—breast cancer	6.78e-05	0.000167	CcSEcCtD
Risedronate—Vertigo—Methotrexate—breast cancer	6.78e-05	0.000167	CcSEcCtD
Risedronate—Gastrointestinal pain—Capecitabine—breast cancer	6.76e-05	0.000167	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—breast cancer	6.76e-05	0.000167	CcSEcCtD
Risedronate—Body temperature increased—Docetaxel—breast cancer	6.75e-05	0.000167	CcSEcCtD
Risedronate—Abdominal pain—Docetaxel—breast cancer	6.75e-05	0.000167	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—breast cancer	6.7e-05	0.000165	CcSEcCtD
Risedronate—Dizziness—Paclitaxel—breast cancer	6.66e-05	0.000164	CcSEcCtD
Risedronate—PTGS2—Disease—CUL5—breast cancer	6.63e-05	0.000618	CbGpPWpGaD
Risedronate—Cough—Methotrexate—breast cancer	6.58e-05	0.000162	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—breast cancer	6.57e-05	0.000162	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	6.57e-05	0.000612	CbGpPWpGaD
Risedronate—Urticaria—Capecitabine—breast cancer	6.57e-05	0.000162	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	6.55e-05	0.00061	CbGpPWpGaD
Risedronate—Abdominal pain—Capecitabine—breast cancer	6.54e-05	0.000161	CcSEcCtD
Risedronate—Body temperature increased—Capecitabine—breast cancer	6.54e-05	0.000161	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—breast cancer	6.53e-05	0.000161	CcSEcCtD
Risedronate—PTGS2—Metabolism—COX11—breast cancer	6.53e-05	0.000608	CbGpPWpGaD
Risedronate—Anaemia—Epirubicin—breast cancer	6.52e-05	0.000161	CcSEcCtD
Risedronate—FDPS—Metabolism—MTHFR—breast cancer	6.52e-05	0.000607	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	6.46e-05	0.000602	CbGpPWpGaD
Risedronate—Flatulence—Doxorubicin—breast cancer	6.44e-05	0.000159	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	6.42e-05	0.000598	CbGpPWpGaD
Risedronate—Chest pain—Methotrexate—breast cancer	6.42e-05	0.000158	CcSEcCtD
Risedronate—Arthralgia—Methotrexate—breast cancer	6.42e-05	0.000158	CcSEcCtD
Risedronate—Myalgia—Methotrexate—breast cancer	6.42e-05	0.000158	CcSEcCtD
Risedronate—Vomiting—Paclitaxel—breast cancer	6.41e-05	0.000158	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	6.38e-05	0.000157	CcSEcCtD
Risedronate—Rash—Paclitaxel—breast cancer	6.35e-05	0.000157	CcSEcCtD
Risedronate—Dermatitis—Paclitaxel—breast cancer	6.35e-05	0.000157	CcSEcCtD
Risedronate—Vertigo—Epirubicin—breast cancer	6.34e-05	0.000156	CcSEcCtD
Risedronate—Syncope—Epirubicin—breast cancer	6.33e-05	0.000156	CcSEcCtD
Risedronate—Back pain—Doxorubicin—breast cancer	6.32e-05	0.000156	CcSEcCtD
Risedronate—Headache—Paclitaxel—breast cancer	6.31e-05	0.000156	CcSEcCtD
Risedronate—Hypersensitivity—Docetaxel—breast cancer	6.29e-05	0.000155	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—breast cancer	6.28e-05	0.000155	CcSEcCtD
Risedronate—PTGS2—Disease—RSPO3—breast cancer	6.23e-05	0.000581	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	6.23e-05	0.00058	CbGpPWpGaD
Risedronate—Loss of consciousness—Epirubicin—breast cancer	6.2e-05	0.000153	CcSEcCtD
Risedronate—Cough—Epirubicin—breast cancer	6.16e-05	0.000152	CcSEcCtD
Risedronate—Asthenia—Docetaxel—breast cancer	6.13e-05	0.000151	CcSEcCtD
Risedronate—Infection—Methotrexate—breast cancer	6.12e-05	0.000151	CcSEcCtD
Risedronate—Hypertension—Epirubicin—breast cancer	6.09e-05	0.00015	CcSEcCtD
Risedronate—Hypersensitivity—Capecitabine—breast cancer	6.09e-05	0.00015	CcSEcCtD
Risedronate—PTGS2—Disease—WNT10B—breast cancer	6.06e-05	0.000565	CbGpPWpGaD
Risedronate—Pruritus—Docetaxel—breast cancer	6.04e-05	0.000149	CcSEcCtD
Risedronate—Nervous system disorder—Methotrexate—breast cancer	6.04e-05	0.000149	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—breast cancer	6.04e-05	0.000149	CcSEcCtD
Risedronate—FDPS—Metabolism—CAV1—breast cancer	6.02e-05	0.00056	CbGpPWpGaD
Risedronate—Myalgia—Epirubicin—breast cancer	6.01e-05	0.000148	CcSEcCtD
Risedronate—Arthralgia—Epirubicin—breast cancer	6.01e-05	0.000148	CcSEcCtD
Risedronate—Chest pain—Epirubicin—breast cancer	6.01e-05	0.000148	CcSEcCtD
Risedronate—Anxiety—Epirubicin—breast cancer	5.99e-05	0.000148	CcSEcCtD
Risedronate—Nausea—Paclitaxel—breast cancer	5.98e-05	0.000148	CcSEcCtD
Risedronate—Skin disorder—Methotrexate—breast cancer	5.98e-05	0.000147	CcSEcCtD
Risedronate—PTGS2—Metabolism—SHMT1—breast cancer	5.97e-05	0.000556	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CDA—breast cancer	5.97e-05	0.000556	CbGpPWpGaD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	5.97e-05	0.000147	CcSEcCtD
Risedronate—Asthenia—Capecitabine—breast cancer	5.93e-05	0.000146	CcSEcCtD
Risedronate—PTGS2—Disease—GPI—breast cancer	5.91e-05	0.00055	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	5.9e-05	0.000549	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—HRAS—breast cancer	5.88e-05	0.000548	CbGpPWpGaD
Risedronate—Dry mouth—Epirubicin—breast cancer	5.88e-05	0.000145	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—MAPK3—breast cancer	5.87e-05	0.000547	CbGpPWpGaD
Risedronate—Vertigo—Doxorubicin—breast cancer	5.87e-05	0.000145	CcSEcCtD
Risedronate—Syncope—Doxorubicin—breast cancer	5.86e-05	0.000144	CcSEcCtD
Risedronate—Pruritus—Capecitabine—breast cancer	5.85e-05	0.000144	CcSEcCtD
Risedronate—Diarrhoea—Docetaxel—breast cancer	5.84e-05	0.000144	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	5.84e-05	0.000544	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLCO1B1—breast cancer	5.75e-05	0.000536	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC2A5—breast cancer	5.75e-05	0.000536	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.75e-05	0.000535	CbGpPWpGaD
Risedronate—Loss of consciousness—Doxorubicin—breast cancer	5.74e-05	0.000142	CcSEcCtD
Risedronate—Infection—Epirubicin—breast cancer	5.72e-05	0.000141	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—MYC—breast cancer	5.71e-05	0.000532	CbGpPWpGaD
Risedronate—Cough—Doxorubicin—breast cancer	5.7e-05	0.000141	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—TGFB1—breast cancer	5.69e-05	0.00053	CbGpPWpGaD
Risedronate—Shock—Epirubicin—breast cancer	5.67e-05	0.00014	CcSEcCtD
Risedronate—Diarrhoea—Capecitabine—breast cancer	5.66e-05	0.00014	CcSEcCtD
Risedronate—Nervous system disorder—Epirubicin—breast cancer	5.65e-05	0.000139	CcSEcCtD
Risedronate—Dizziness—Docetaxel—breast cancer	5.65e-05	0.000139	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	5.64e-05	0.000525	CbGpPWpGaD
Risedronate—Hypertension—Doxorubicin—breast cancer	5.64e-05	0.000139	CcSEcCtD
Risedronate—PTGS2—Disease—DLL4—breast cancer	5.64e-05	0.000525	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	5.62e-05	0.000523	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Methotrexate—breast cancer	5.61e-05	0.000138	CcSEcCtD
Risedronate—Skin disorder—Epirubicin—breast cancer	5.6e-05	0.000138	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—EGFR—breast cancer	5.58e-05	0.00052	CbGpPWpGaD
Risedronate—Insomnia—Methotrexate—breast cancer	5.57e-05	0.000137	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—breast cancer	5.56e-05	0.000137	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—breast cancer	5.56e-05	0.000137	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—breast cancer	5.56e-05	0.000137	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	5.56e-05	0.000518	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APRT—breast cancer	5.55e-05	0.000517	CbGpPWpGaD
Risedronate—Anxiety—Doxorubicin—breast cancer	5.54e-05	0.000137	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	5.54e-05	0.000516	CbGpPWpGaD
Risedronate—Paraesthesia—Methotrexate—breast cancer	5.53e-05	0.000136	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	5.52e-05	0.000136	CcSEcCtD
Risedronate—Dyspnoea—Methotrexate—breast cancer	5.49e-05	0.000135	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	5.48e-05	0.00051	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CG—breast cancer	5.48e-05	0.00051	CbGpPWpGaD
Risedronate—Dizziness—Capecitabine—breast cancer	5.47e-05	0.000135	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—FASN—breast cancer	5.45e-05	0.000508	CbGpPWpGaD
Risedronate—Dry mouth—Doxorubicin—breast cancer	5.44e-05	0.000134	CcSEcCtD
Risedronate—Vomiting—Docetaxel—breast cancer	5.43e-05	0.000134	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	5.43e-05	0.000506	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—breast cancer	5.43e-05	0.000505	CbGpPWpGaD
Risedronate—Dyspepsia—Methotrexate—breast cancer	5.42e-05	0.000134	CcSEcCtD
Risedronate—Rash—Docetaxel—breast cancer	5.38e-05	0.000133	CcSEcCtD
Risedronate—Dermatitis—Docetaxel—breast cancer	5.38e-05	0.000133	CcSEcCtD
Risedronate—Headache—Docetaxel—breast cancer	5.35e-05	0.000132	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—TNF—breast cancer	5.32e-05	0.000495	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Methotrexate—breast cancer	5.31e-05	0.000131	CcSEcCtD
Risedronate—Fatigue—Methotrexate—breast cancer	5.31e-05	0.000131	CcSEcCtD
Risedronate—PTGS2—Disease—LDHB—breast cancer	5.3e-05	0.000494	CbGpPWpGaD
Risedronate—PTGS2—Disease—HPSE—breast cancer	5.3e-05	0.000494	CbGpPWpGaD
Risedronate—PTGS2—Disease—SFRP2—breast cancer	5.3e-05	0.000494	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPL31—breast cancer	5.3e-05	0.000494	CbGpPWpGaD
Risedronate—Infection—Doxorubicin—breast cancer	5.3e-05	0.000131	CcSEcCtD
Risedronate—Pain—Methotrexate—breast cancer	5.26e-05	0.00013	CcSEcCtD
Risedronate—Vomiting—Capecitabine—breast cancer	5.26e-05	0.00013	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Epirubicin—breast cancer	5.25e-05	0.000129	CcSEcCtD
Risedronate—Shock—Doxorubicin—breast cancer	5.24e-05	0.000129	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—breast cancer	5.23e-05	0.000129	CcSEcCtD
Risedronate—PTGS2—Metabolism—ESRRA—breast cancer	5.22e-05	0.000486	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ANGPTL4—breast cancer	5.22e-05	0.000486	CbGpPWpGaD
Risedronate—Rash—Capecitabine—breast cancer	5.21e-05	0.000129	CcSEcCtD
Risedronate—Insomnia—Epirubicin—breast cancer	5.21e-05	0.000129	CcSEcCtD
Risedronate—Dermatitis—Capecitabine—breast cancer	5.21e-05	0.000128	CcSEcCtD
Risedronate—Headache—Capecitabine—breast cancer	5.18e-05	0.000128	CcSEcCtD
Risedronate—Skin disorder—Doxorubicin—breast cancer	5.18e-05	0.000128	CcSEcCtD
Risedronate—Paraesthesia—Epirubicin—breast cancer	5.17e-05	0.000128	CcSEcCtD
Risedronate—Dyspnoea—Epirubicin—breast cancer	5.14e-05	0.000127	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	5.07e-05	0.000473	CbGpPWpGaD
Risedronate—Nausea—Docetaxel—breast cancer	5.07e-05	0.000125	CcSEcCtD
Risedronate—Dyspepsia—Epirubicin—breast cancer	5.07e-05	0.000125	CcSEcCtD
Risedronate—Gastrointestinal pain—Methotrexate—breast cancer	5.03e-05	0.000124	CcSEcCtD
Risedronate—PTGS2—Disease—VCP—breast cancer	5.02e-05	0.000468	CbGpPWpGaD
Risedronate—PTGS2—Disease—HMMR—breast cancer	5.02e-05	0.000468	CbGpPWpGaD
Risedronate—PTGS2—Disease—ABCC1—breast cancer	5.02e-05	0.000468	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	4.97e-05	0.000463	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Epirubicin—breast cancer	4.97e-05	0.000123	CcSEcCtD
Risedronate—Fatigue—Epirubicin—breast cancer	4.97e-05	0.000123	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	4.96e-05	0.000462	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPI—breast cancer	4.95e-05	0.000461	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HADHB—breast cancer	4.95e-05	0.000461	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS4X—breast cancer	4.94e-05	0.00046	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFBI—breast cancer	4.94e-05	0.00046	CbGpPWpGaD
Risedronate—Pain—Epirubicin—breast cancer	4.93e-05	0.000122	CcSEcCtD
Risedronate—Constipation—Epirubicin—breast cancer	4.93e-05	0.000122	CcSEcCtD
Risedronate—Nausea—Capecitabine—breast cancer	4.91e-05	0.000121	CcSEcCtD
Risedronate—Urticaria—Methotrexate—breast cancer	4.89e-05	0.000121	CcSEcCtD
Risedronate—Body temperature increased—Methotrexate—breast cancer	4.87e-05	0.00012	CcSEcCtD
Risedronate—Abdominal pain—Methotrexate—breast cancer	4.87e-05	0.00012	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.86e-05	0.00012	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	4.84e-05	0.000451	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	4.83e-05	0.00045	CbGpPWpGaD
Risedronate—Insomnia—Doxorubicin—breast cancer	4.82e-05	0.000119	CcSEcCtD
Risedronate—FDPS—Metabolism—PIK3CD—breast cancer	4.82e-05	0.000449	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	4.79e-05	0.000447	CbGpPWpGaD
Risedronate—Paraesthesia—Doxorubicin—breast cancer	4.79e-05	0.000118	CcSEcCtD
Risedronate—FDPS—Metabolism—ALB—breast cancer	4.75e-05	0.000443	CbGpPWpGaD
Risedronate—Dyspnoea—Doxorubicin—breast cancer	4.75e-05	0.000117	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	4.74e-05	0.000441	CbGpPWpGaD
Risedronate—PTGS2—Disease—ELL—breast cancer	4.72e-05	0.00044	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDH7A1—breast cancer	4.72e-05	0.00044	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDH1A1—breast cancer	4.72e-05	0.00044	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Epirubicin—breast cancer	4.71e-05	0.000116	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—breast cancer	4.69e-05	0.000116	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—TP53—breast cancer	4.69e-05	0.000437	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	4.68e-05	0.000436	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	4.67e-05	0.000435	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	4.67e-05	0.000435	CbGpPWpGaD
Risedronate—Gastrointestinal disorder—Doxorubicin—breast cancer	4.6e-05	0.000114	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—breast cancer	4.6e-05	0.000113	CcSEcCtD
Risedronate—Urticaria—Epirubicin—breast cancer	4.58e-05	0.000113	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	4.57e-05	0.000426	CbGpPWpGaD
Risedronate—Pain—Doxorubicin—breast cancer	4.56e-05	0.000112	CcSEcCtD
Risedronate—Constipation—Doxorubicin—breast cancer	4.56e-05	0.000112	CcSEcCtD
Risedronate—Body temperature increased—Epirubicin—breast cancer	4.55e-05	0.000112	CcSEcCtD
Risedronate—Abdominal pain—Epirubicin—breast cancer	4.55e-05	0.000112	CcSEcCtD
Risedronate—FDPS—Metabolism—NOS3—breast cancer	4.55e-05	0.000424	CbGpPWpGaD
Risedronate—Hypersensitivity—Methotrexate—breast cancer	4.53e-05	0.000112	CcSEcCtD
Risedronate—PTGS2—Metabolism—ADSL—breast cancer	4.53e-05	0.000422	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—UMPS—breast cancer	4.53e-05	0.000422	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PHGDH—breast cancer	4.53e-05	0.000422	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—FHL2—breast cancer	4.53e-05	0.000422	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NME1—breast cancer	4.53e-05	0.000422	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LDHB—breast cancer	4.44e-05	0.000413	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—BRIP1—breast cancer	4.44e-05	0.000413	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HPSE—breast cancer	4.44e-05	0.000413	CbGpPWpGaD
Risedronate—PTGS2—Disease—HEY2—breast cancer	4.42e-05	0.000412	CbGpPWpGaD
Risedronate—Asthenia—Methotrexate—breast cancer	4.42e-05	0.000109	CcSEcCtD
Risedronate—PTGS2—Disease—RPS6KB2—breast cancer	4.37e-05	0.000407	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Doxorubicin—breast cancer	4.36e-05	0.000108	CcSEcCtD
Risedronate—Pruritus—Methotrexate—breast cancer	4.35e-05	0.000107	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	4.33e-05	0.000404	CbGpPWpGaD
Risedronate—PTGS2—Disease—IDH1—breast cancer	4.32e-05	0.000402	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—breast cancer	4.29e-05	0.0004	CbGpPWpGaD
Risedronate—Hypersensitivity—Epirubicin—breast cancer	4.24e-05	0.000105	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—breast cancer	4.23e-05	0.000104	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	4.22e-05	0.000393	CbGpPWpGaD
Risedronate—Abdominal pain—Doxorubicin—breast cancer	4.21e-05	0.000104	CcSEcCtD
Risedronate—Body temperature increased—Doxorubicin—breast cancer	4.21e-05	0.000104	CcSEcCtD
Risedronate—Diarrhoea—Methotrexate—breast cancer	4.21e-05	0.000104	CcSEcCtD
Risedronate—PTGS2—Metabolism—ABCC1—breast cancer	4.21e-05	0.000392	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTA3—breast cancer	4.21e-05	0.000392	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMMR—breast cancer	4.21e-05	0.000392	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CB—breast cancer	4.2e-05	0.000391	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—breast cancer	4.16e-05	0.000387	CbGpPWpGaD
Risedronate—PTGS2—Disease—TLE3—breast cancer	4.14e-05	0.000385	CbGpPWpGaD
Risedronate—Asthenia—Epirubicin—breast cancer	4.13e-05	0.000102	CcSEcCtD
Risedronate—PTGS2—Disease—HEY1—breast cancer	4.1e-05	0.000382	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARGC1B—breast cancer	4.08e-05	0.00038	CbGpPWpGaD
Risedronate—Pruritus—Epirubicin—breast cancer	4.08e-05	0.000101	CcSEcCtD
Risedronate—Dizziness—Methotrexate—breast cancer	4.07e-05	0.0001	CcSEcCtD
Risedronate—PTGS2—Disease—DLL1—breast cancer	4.02e-05	0.000374	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPL23A—breast cancer	4.02e-05	0.000374	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	3.99e-05	0.000372	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	3.97e-05	0.00037	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	3.97e-05	0.00037	CbGpPWpGaD
Risedronate—PTGS2—Disease—HIST1H2BC—breast cancer	3.94e-05	0.000367	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAP2K7—breast cancer	3.94e-05	0.000367	CbGpPWpGaD
Risedronate—PTGS2—Disease—HIST1H2BK—breast cancer	3.94e-05	0.000367	CbGpPWpGaD
Risedronate—Diarrhoea—Epirubicin—breast cancer	3.94e-05	9.72e-05	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—breast cancer	3.93e-05	9.69e-05	CcSEcCtD
Risedronate—Vomiting—Methotrexate—breast cancer	3.91e-05	9.65e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	3.88e-05	0.000362	CbGpPWpGaD
Risedronate—Rash—Methotrexate—breast cancer	3.88e-05	9.57e-05	CcSEcCtD
Risedronate—Dermatitis—Methotrexate—breast cancer	3.88e-05	9.56e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	3.87e-05	0.000361	CbGpPWpGaD
Risedronate—Headache—Methotrexate—breast cancer	3.86e-05	9.51e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—CA9—breast cancer	3.85e-05	0.000359	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTA4—breast cancer	3.85e-05	0.000359	CbGpPWpGaD
Risedronate—Asthenia—Doxorubicin—breast cancer	3.82e-05	9.43e-05	CcSEcCtD
Risedronate—Dizziness—Epirubicin—breast cancer	3.81e-05	9.4e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	3.8e-05	0.000354	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	3.8e-05	0.000354	CbGpPWpGaD
Risedronate—Pruritus—Doxorubicin—breast cancer	3.77e-05	9.3e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	3.76e-05	0.00035	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPX2—breast cancer	3.75e-05	0.000349	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTA2—breast cancer	3.75e-05	0.000349	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS7—breast cancer	3.75e-05	0.000349	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS8—breast cancer	3.75e-05	0.000349	CbGpPWpGaD
Risedronate—PTGS2—Disease—DKK1—breast cancer	3.72e-05	0.000346	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SULT1A1—breast cancer	3.7e-05	0.000345	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPX4—breast cancer	3.7e-05	0.000345	CbGpPWpGaD
Risedronate—PTGS2—Disease—ALDOA—breast cancer	3.69e-05	0.000344	CbGpPWpGaD
Risedronate—Vomiting—Epirubicin—breast cancer	3.66e-05	9.03e-05	CcSEcCtD
Risedronate—Nausea—Methotrexate—breast cancer	3.66e-05	9.02e-05	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—breast cancer	3.65e-05	9e-05	CcSEcCtD
Risedronate—PTGS2—Disease—JAG2—breast cancer	3.63e-05	0.000338	CbGpPWpGaD
Risedronate—Rash—Epirubicin—breast cancer	3.63e-05	8.96e-05	CcSEcCtD
Risedronate—Dermatitis—Epirubicin—breast cancer	3.63e-05	8.95e-05	CcSEcCtD
Risedronate—FDPS—Metabolism—PTEN—breast cancer	3.63e-05	0.000338	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—IDH1—breast cancer	3.62e-05	0.000337	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTA1—breast cancer	3.62e-05	0.000337	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	3.62e-05	0.000337	CbGpPWpGaD
Risedronate—Headache—Epirubicin—breast cancer	3.61e-05	8.9e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	3.59e-05	0.000334	CbGpPWpGaD
Risedronate—PTGS2—Disease—WNT1—breast cancer	3.58e-05	0.000334	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NAT2—breast cancer	3.58e-05	0.000333	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC2A2—breast cancer	3.56e-05	0.000331	CbGpPWpGaD
Risedronate—Dizziness—Doxorubicin—breast cancer	3.52e-05	8.69e-05	CcSEcCtD
Risedronate—PTGS2—Disease—MTR—breast cancer	3.48e-05	0.000324	CbGpPWpGaD
Risedronate—Nausea—Epirubicin—breast cancer	3.42e-05	8.44e-05	CcSEcCtD
Risedronate—Vomiting—Doxorubicin—breast cancer	3.39e-05	8.36e-05	CcSEcCtD
Risedronate—Rash—Doxorubicin—breast cancer	3.36e-05	8.29e-05	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—breast cancer	3.36e-05	8.28e-05	CcSEcCtD
Risedronate—Headache—Doxorubicin—breast cancer	3.34e-05	8.24e-05	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	3.3e-05	0.000307	CbGpPWpGaD
Risedronate—PTGS2—Disease—HSPA1B—breast cancer	3.24e-05	0.000302	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.23e-05	0.000301	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	3.19e-05	0.000297	CbGpPWpGaD
Risedronate—Nausea—Doxorubicin—breast cancer	3.17e-05	7.81e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—MED12—breast cancer	3.14e-05	0.000292	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DPYD—breast cancer	3.14e-05	0.000292	CbGpPWpGaD
Risedronate—PTGS2—Disease—ENO1—breast cancer	3.1e-05	0.000289	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDOA—breast cancer	3.09e-05	0.000288	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOA3—breast cancer	3e-05	0.000279	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC2A2—breast cancer	2.98e-05	0.000277	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.95e-05	0.000274	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF3—breast cancer	2.94e-05	0.000273	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CPT1A—breast cancer	2.92e-05	0.000272	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTR—breast cancer	2.92e-05	0.000272	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCG2—breast cancer	2.92e-05	0.000272	CbGpPWpGaD
Risedronate—PTGS2—Disease—JAG1—breast cancer	2.9e-05	0.00027	CbGpPWpGaD
Risedronate—PTGS2—Disease—FASN—breast cancer	2.9e-05	0.00027	CbGpPWpGaD
Risedronate—PTGS2—Disease—PARP1—breast cancer	2.89e-05	0.000269	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HPGDS—breast cancer	2.86e-05	0.000266	CbGpPWpGaD
Risedronate—PTGS2—Disease—CALCA—breast cancer	2.85e-05	0.000266	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HBA1—breast cancer	2.84e-05	0.000265	CbGpPWpGaD
Risedronate—PTGS2—Disease—RPS6—breast cancer	2.82e-05	0.000262	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF4—breast cancer	2.8e-05	0.00026	CbGpPWpGaD
Risedronate—PTGS2—Disease—CXCR4—breast cancer	2.78e-05	0.000259	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTT1—breast cancer	2.77e-05	0.000258	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ACHE—breast cancer	2.77e-05	0.000258	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC2A1—breast cancer	2.75e-05	0.000256	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.69e-05	0.000251	CbGpPWpGaD
Risedronate—PTGS2—Disease—TCF7L2—breast cancer	2.68e-05	0.00025	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP17A1—breast cancer	2.63e-05	0.000245	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ENO1—breast cancer	2.6e-05	0.000242	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTGS1—breast cancer	2.6e-05	0.000242	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.59e-05	0.000241	CbGpPWpGaD
Risedronate—PTGS2—Disease—HSP90AA1—breast cancer	2.59e-05	0.000241	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CA—breast cancer	2.56e-05	0.000238	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.56e-05	0.000238	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP2D6—breast cancer	2.55e-05	0.000237	CbGpPWpGaD
Risedronate—PTGS2—Disease—PRL—breast cancer	2.52e-05	0.000235	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOA2—breast cancer	2.5e-05	0.000233	CbGpPWpGaD
Risedronate—PTGS2—Disease—ADAM10—breast cancer	2.48e-05	0.000231	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—FASN—breast cancer	2.43e-05	0.000226	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—BCHE—breast cancer	2.42e-05	0.000225	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF10—breast cancer	2.41e-05	0.000225	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC5A5—breast cancer	2.39e-05	0.000222	CbGpPWpGaD
Risedronate—PTGS2—Disease—PDGFA—breast cancer	2.33e-05	0.000217	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NQO1—breast cancer	2.31e-05	0.000215	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SLC2A1—breast cancer	2.31e-05	0.000215	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFBR2—breast cancer	2.3e-05	0.000214	CbGpPWpGaD
Risedronate—PTGS2—Disease—ITPR1—breast cancer	2.26e-05	0.00021	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.26e-05	0.00021	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP3A4—breast cancer	2.25e-05	0.000209	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERBB4—breast cancer	2.24e-05	0.000209	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT5A—breast cancer	2.24e-05	0.000209	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP1B1—breast cancer	2.21e-05	0.000206	CbGpPWpGaD
Risedronate—PTGS2—Disease—SMAD4—breast cancer	2.17e-05	0.000202	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HSP90AA1—breast cancer	2.17e-05	0.000202	CbGpPWpGaD
Risedronate—PTGS2—Disease—HES1—breast cancer	2.12e-05	0.000198	CbGpPWpGaD
Risedronate—PTGS2—Disease—NCOR1—breast cancer	2.11e-05	0.000197	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOA1—breast cancer	2.11e-05	0.000196	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—breast cancer	2.09e-05	0.000195	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGF1—breast cancer	2.09e-05	0.000194	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—STK11—breast cancer	2.08e-05	0.000194	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP19A1—breast cancer	2.08e-05	0.000194	CbGpPWpGaD
Risedronate—PTGS2—Disease—NRG1—breast cancer	2.07e-05	0.000193	CbGpPWpGaD
Risedronate—PTGS2—Disease—H2AFX—breast cancer	2.06e-05	0.000192	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERCC2—breast cancer	1.98e-05	0.000185	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.95e-05	0.000182	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERBB3—breast cancer	1.94e-05	0.000181	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGFR2—breast cancer	1.94e-05	0.00018	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—COMT—breast cancer	1.93e-05	0.00018	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTP1—breast cancer	1.92e-05	0.000179	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMOX1—breast cancer	1.9e-05	0.000177	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ITPR1—breast cancer	1.89e-05	0.000176	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTHFR—breast cancer	1.86e-05	0.000174	CbGpPWpGaD
Risedronate—PTGS2—Disease—TERT—breast cancer	1.86e-05	0.000173	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCB1—breast cancer	1.82e-05	0.00017	CbGpPWpGaD
Risedronate—PTGS2—Disease—FGFR1—breast cancer	1.81e-05	0.000168	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—TYMS—breast cancer	1.79e-05	0.000167	CbGpPWpGaD
Risedronate—PTGS2—Disease—HIF1A—breast cancer	1.78e-05	0.000166	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLA2G4A—breast cancer	1.77e-05	0.000165	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NCOR1—breast cancer	1.77e-05	0.000165	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTM1—breast cancer	1.77e-05	0.000165	CbGpPWpGaD
Risedronate—PTGS2—Disease—CAV1—breast cancer	1.72e-05	0.00016	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPX1—breast cancer	1.69e-05	0.000158	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP1A1—breast cancer	1.68e-05	0.000156	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ERCC2—breast cancer	1.66e-05	0.000155	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS2—breast cancer	1.62e-05	0.000151	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOTCH1—breast cancer	1.6e-05	0.000149	CbGpPWpGaD
Risedronate—PTGS2—Disease—APC—breast cancer	1.57e-05	0.000146	CbGpPWpGaD
Risedronate—PTGS2—Disease—KIT—breast cancer	1.57e-05	0.000146	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTHFR—breast cancer	1.56e-05	0.000145	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGF—breast cancer	1.55e-05	0.000144	CbGpPWpGaD
Risedronate—PTGS2—Disease—BRAF—breast cancer	1.47e-05	0.000137	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CAV1—breast cancer	1.44e-05	0.000134	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT2—breast cancer	1.43e-05	0.000134	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CD—breast cancer	1.38e-05	0.000128	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.38e-05	0.000128	CbGpPWpGaD
Risedronate—PTGS2—Disease—SERPINE1—breast cancer	1.36e-05	0.000127	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CG—breast cancer	1.31e-05	0.000122	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS3—breast cancer	1.3e-05	0.000121	CbGpPWpGaD
Risedronate—PTGS2—Disease—MDM2—breast cancer	1.23e-05	0.000115	CbGpPWpGaD
Risedronate—PTGS2—Disease—RAF1—breast cancer	1.23e-05	0.000115	CbGpPWpGaD
Risedronate—PTGS2—Disease—ERBB2—breast cancer	1.22e-05	0.000113	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTOR—breast cancer	1.2e-05	0.000112	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CB—breast cancer	1.2e-05	0.000112	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD4—breast cancer	1.2e-05	0.000112	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CD—breast cancer	1.15e-05	0.000107	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—breast cancer	1.14e-05	0.000106	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1B—breast cancer	1.13e-05	0.000105	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NOS3—breast cancer	1.09e-05	0.000101	CbGpPWpGaD
Risedronate—PTGS2—Disease—CTNNB1—breast cancer	1.06e-05	9.92e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—CDKN1A—breast cancer	1.04e-05	9.69e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—PTEN—breast cancer	1.04e-05	9.66e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CB—breast cancer	1.01e-05	9.37e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—SRC—breast cancer	9.62e-06	8.96e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT3—breast cancer	9.28e-06	8.64e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAPK3—breast cancer	8.86e-06	8.26e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTEN—breast cancer	8.69e-06	8.09e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—MYC—breast cancer	8.62e-06	8.03e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFB1—breast cancer	8.6e-06	8.01e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGFR—breast cancer	8.43e-06	7.86e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—KRAS—breast cancer	7.97e-06	7.42e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—PIK3CA—breast cancer	7.32e-06	6.82e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—HRAS—breast cancer	6.77e-06	6.31e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—breast cancer	6.48e-06	6.04e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CA—breast cancer	6.13e-06	5.71e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—breast cancer	5.98e-06	5.57e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—breast cancer	5.01e-06	4.66e-05	CbGpPWpGaD
